Home News Pfizer maintains sales forecast for Covid-19 pandemic products in 2022

Pfizer maintains sales forecast for Covid-19 pandemic products in 2022

67
0

Several countries have eased pandemic restrictions, reducing the rules on wearing a mask and quarantine, even though the number of cases is rising in some regions.

The company said it expects $ 22 billion in sales this year for its anti-Covid Paxlovid treatment, compared to the average analyst expectation of $ 26.1 billion, according to Refinitiv.

Pfizer previously said its $ 22 billion forecast for pill sales is only a fraction of the company’s 120 million treatments it can produce this year.

The company’s reluctance to increase this forecast could signal a lack of new sales contracts for the first quarter.

Read:   Fed Chairman: The US should not take the global status of the dollar for granted. Digital dollar needed

Pfizer also reiterated its forecast of $ 32 billion in sales of the Covid vaccine it developed with BioNTech in 2022.

Pfizer has increased its Covid-19 vaccine sales forecast quarterly in 2021.

If you like this article, we look forward to joining the community of readers on our Facebook page, with a Like below:

Previous articleThe EU plans to replace two-thirds of the Russian gas used by the end of the year
Next articleNickel and lithium resources will reach the production of 14 million electric cars in 2023